Copyright
©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 14, 2005; 11(10): 1445-1451
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1445
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1445
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma
Hai-Gang Li, Xi-Ming Shen, Hong Zeng, Yun-Jie Zeng, Department of Pathology, The Second Affiliated Hospital to Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China
De-Rong Xie, Department of Oncology, The Second Affiliated Hospital to Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China
Hong-Hao Li, Department of Surgery, The Second Affiliated Hospital to Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China
Author contributions: All authors contributed equally to the work.
Supported by the Major Programs of Health Bureau of Guangdong Province, No. A200194
Correspondence to: De-Rong Xie, Department of Oncology, Second Affiliated Hospital to Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China. xiederong@21cn.com
Telephone: +86-20-81332616 Fax: +86-20-81332781
Received: August 30, 2004
Revised: August 31, 2004
Accepted: December 3, 2004
Published online: March 14, 2005
Revised: August 31, 2004
Accepted: December 3, 2004
Published online: March 14, 2005
Core Tip